Evaluation of experimental autoimmune uveitis in mice treated with FTY720

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 5, 2010, Pages 2568-2574

  Commodaro, Alessandra Gonçalves ^a   Peron, Jean Pierre S ^a   Lopes, Camila Takao ^b   Arslanian, Christina ^a   Rubens Jr , Belfort ^a   Rizzo, Luiz Vicente ^a,c   Bueno, Valquiria ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c Albert Einstein Jewish Institute for Education and Research   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; FINGOLIMOD; GAMMA INTERFERON; TRANSCRIPTION FACTOR FOXP3; CYTOKINE; DRUG DERIVATIVE; EYE PROTEIN; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR ALPHA; INTERPHOTORECEPTOR RETINOID BINDING PROTEIN; INTERSTITIAL RETINOL-BINDING PROTEIN; PEPTIDE FRAGMENT; PROPANEDIOL DERIVATIVE; RETINOL BINDING PROTEIN; SPHINGOSINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE UVEITIS; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG EFFICACY; HISTOPATHOLOGY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SPLEEN CELL; T LYMPHOCYTE; UVEITIS; ANIMAL; AUTOIMMUNE DISEASE; BLOOD; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CELL MOTION; DIGESTIVE TRACT INTUBATION; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOLOGY; LYMPH NODE; METABOLISM; PATHOLOGY;

ANIMALS; AUTOIMMUNE DISEASES; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EYE PROTEINS; FLOW CYTOMETRY; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTUBATION, GASTROINTESTINAL; LYMPH NODES; MICE; PEPTIDE FRAGMENTS; PROPYLENE GLYCOLS; RETINOL-BINDING PROTEINS; SPHINGOSINE; T-LYMPHOCYTES, REGULATORY; UVEITIS, POSTERIOR;

EID: 77952523409     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-4769     Document Type: Article

References (44)

1. + T cell line and clone that induce experimental autoimmune uveoretinitis in B10. A mice. J Immunol. 1996;156:1654-1660.
2. Mochizuki M, Kuwabara T, McAllister C, et al. Adoptive transfer of experimental autoimmune uveoretinitis in rats: immunopathogenic mechanisms and histologic features. Invest Ophthalmol Vis Sci. 1985;26:1-9.
3. Caspi RR, Roberge FG, Chan CC, et al. A new model of autoimmune disease: experimental autoimmune uveoretinitis induced in mice with two different retinal antigens. J Immunol. 1988;140:1490-1495.
4. Xu H, Rizzo LV, Silver PB, Caspi RR. Uveitogenicity is associated with a Th1-like lymphokine profile: cytokine-dependent modulation of early and committed effector T cells in experimental autoimmune uveitis. Cell Immunol. 1997;178:69-78.
5. Sonoda KH, Yoshimura T, Takeda A, et al. WSX-1 plays a significant role for the initiation of experimental autoimmune uveitis. Int Immunol. 2007;19:93-98.
6. Yokoi H, Kato K, Kezuka T, et al. Prevention of experimental autoimmune uveoretinitis by monoclonal antibody to interleukin-12. Eur J Immunol. 1997;27:641-646.
7. Yoshimura T, Sonoda KH, Miyazaki Y, et al. Differential roles for IFN-gamma and IL-17 in experimental autoimmune uveoretinitis. Int Immunol. 2008;20:209-214.
8. Amadi-Obi A, Yu CR, Liu X, et al. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/ STAT1. Nat Med. 2007;13:711-718.
9. Caspi RR, Chan CC, Fujino Y, et al. Genetic factors in susceptibility and resistance to experimental autoimmune uveoretinitis. Curr Eye Res. 1992;11:81-86.
10. Silver PB, Rizzo LV, Chan CC, et al. Identification of a major pathogenic epitope in the human IRBP molecule recognized by mice of the H-2r haplotype. Invest Ophthalmol Vis Sci. 1995;36:946-954.
11. Hara Y, Caspi RR, Wiggert B, et al. Suppression of experimental autoimmune uveitis in mice by induction of anterior chamberassociated immune deviation with interphotoreceptor retinoidbinding protein. J Immunol. 1992;148:1685-1692.
12. Hara Y, Caspi RR, Wiggert B, et al. Use of ACAID to suppress interphotoreceptor retinoid binding protein-induced experimental autoimmune uveitis. Curr Eye Res. 1992;11:97-100.
13. Thurau SR, Chan CC, Nussenblatt RB, Caspi RR. Oral tolerance in a murine model of relapsing experimental autoimmune uveoretinitis (EAU): induction of protective tolerance in primed animals. Clin Exp Immunol. 1997;109:370-376.
14. Rizzo LV, Miller-Rivero NE, Chan CC, et al. Interleukin-2 treatment potentiates induction of oral tolerance in a murine model of autoimmunity. J Clin Invest. 1994;94:1668-1672.
15. Martin AP, de Moraes LV, Tadokoro CE, et al. Administration of a peptide inhibitor of alpha4-integrin inhibits the development of experimental autoimmune uveitis. Invest Ophthalmol Vis Sci. 2005;46:2056-2063.
16. Toscano MA, Commodaro AG, Ilarregui JM, et al. Galectin-1 suppresses autoimmune retinal disease by promoting concomitant Th2-and T regulatory-mediated anti-inflammatory responses. J Immunol. 2006;176:6323-6332.
17. Ilarregui JM, Croci DO, Bianco GA, et al. Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10. Nat Immunol. 2009;10:981-991.
18. Saoudi A, Kuhn J, Huygen K, et al. TH2 activated cells prevent experimental autoimmune uveoretinitis, a TH1-dependent autoimmune disease. Eur J Immunol. 1993;23:3096-3103.
19. Rizzo LV, Xu H, Chan CC, et al. IL-10 has a protective role in experimental autoimmune uveoretinitis. Int Immunol. 1998;10:807-814.
20. Rizzo LV, Morawetz RA, Miller-Rivero NE, et al. IL-4 and IL-10 are both required for the induction of oral tolerance. J Immunol. 1999;162:2613-2622.
21. Cunningham MA, Austin BA, Li Z, et al. LX211 (voclosporin) suppresses experimental uveitis and inhibits human T cells. Invest Ophthalmol Vis Sci. 2009;50:249-255.
22. Ke Y, Liu K, Huang GQ, et al. Anti-inflammatory role of IL-17 in experimental autoimmune uveitis. J Immunol. 2009;182:3183-3190.
23. Lee DJ, Biros DJ, Taylor AW. Injection of an alpha-melanocyte stimulating hormone expression plasmid is effective in suppressing experimental autoimmune uveitis. Int Immunopharmacol. 2009;9:1079-1086.
24. Graler MH, Goetzl EJ. The immunosuppressant FTY720 downregulates sphingosine 1-phosphate G-protein-coupled receptors. FASEB. J 2004;18:551-553.
25. Matloubian M, Lo CG, Cinamon G, et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature. 2004;427:355-360.
26. Zhang EP, Muller A, Ignatius R, Hoffmann F. Significant prolongation of orthotopic corneal-graft survival in FTY720-treated mice. Transplantation. 2003;76:1511-1513.
27. Mayer K, Birnbaum F, Reinhard T, et al. FTY720 prolongs clear corneal allograft survival with a differential effect on different lymphocyte populations. Br J Ophthalmol. 2004;88:915-919.
28. Kurose S, Ikeda E, Tokiwa M, et al. Effects of FTY720, a novel immunosuppressant, on experimental autoimmune uveoretinitis in rats. Exp Eye Res. 2000;70:7-15.
29. Raveney BJ, Copland DA, Nicholson LB, Dick AD. Fingolimod (FTY720) as an acute rescue therapy for intraocular inflammatory disease. Arch Ophthalmol. 2008;126:1390-1395.
30. + regulators. J Immunol. 2008;180:7636-7647.
31. + T-regulatory cells and enhances their functional activity. J Immunol. 2005;175:7973-7980.
32. + regulatory T cells. J Immunol. 2007;178:2458-2468.
33. Zhang Z, Zhang ZY, Fauser U, Schluesener HJ. FTY720 ameliorates experimental autoimmune neuritis by inhibition of lymphocyte and monocyte infiltration into peripheral nerves. Exp Neurol. 2008;210:681-690.
34. Yagi H, Kamba R, Chiba K, et al. Immunosuppressant FTY720 inhibits thymocyte emigration. Eur J Immunol. 2000;30:1435-1444.
35. Sun B, Rizzo LV, Sun SH, et al. Genetic susceptibility to experimental autoimmune uveitis involves more than a predisposition to generate a T helper-1-like or a T helper-2-like response. J Immunol. 1997;159:1004-1011.
36. Caspi RR, Silver PB, Chan CC, et al. Genetic susceptibility to experimental autoimmune uveoretinitis in the rat is associated with an elevated Th1 response. J Immunol. 1996;157:2668-2675.
37. + regulatory T cell functioning in collagen-induced arthritis: an important factor in pathogenesis, counter-regulated by endogenous IFN-gamma. Arthritis Res Ther. 2005;7:R402-R415.
38. Wei B, Baker S, Wieckiewicz J, Wood KJ. IFN-gamma triggered STAT1-PKB/AKT signaling pathway influences the function of alloantigen reactive regulatory T Cells. Am J Transplant. 2010;10:69-80.
39. Yopp AC, Ochando JC, Mao M, et al. Sphingosine 1-phosphate receptors regulate chemokine-driven transendothelial migration of lymph node but not splenic T cells. J Immunol. 2005;175:2913-2924.
40. Chiba K, Yanagawa Y, Masubuchi Y, et al. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing. J Immunol. 1998; 160:5037-5044.
41. Morris MA, Gibb DR, Picard F, et al. Transient T cell accumulation in lymph nodes and sustained lymphopenia in mice treated with FTY720. Eur J Immunol. 2005;35:3570-3580.
42. Xu H, Forrester JV, Liversidge J, Crane IJ. Leukocyte trafficking in experimental autoimmune uveitis: breakdown of blood-retinal barrier and upregulation of cellular adhesion molecules. Invest Ophthalmol Vis Sci. 2003;44:226-234.
43. Jiang HR, Lumsden L, Forrester JV. Macrophages and dendritic cells in IRBP-induced experimental autoimmune uveoretinitis in B10RIII mice. Invest Ophthalmol Vis Sci. 1999;4:3177-3185.
44. Chan CC, Caspi RR, Ni M, et al. Pathology of experimental autoimmune uveoretinitis in mice. J Autoimmun. 1990;3:247-255.